Hayal İsmailov
Hayal İsmailov has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Ali Sahap Odacilar
Department of Perinatology, University of Health Sciences Zeynep Kamil Women’s and Children’s Disease Training and Research Hospital, Istanbul, Turkey
2 shared publications - Aydın Öcal
Department of Obstetrics and Gynecology , Haseki Training and Research Hospital Affiliated with the University of Health Sciences , Istanbul , Türkiye
2 shared publications - Gizem Elif Dizdaroğulları
Department of Perinatology, University of Health Sciences Zeynep Kamil Women’s and Children’s Disease Training and Research Hospital, Istanbul, Turkey
2 shared publications - Münip Akalın
Department of Perinatology Marmara University Pendik Training and Research Hospital Istanbul Turkey
2 shared publications - Oya Demirci
Department of Obstetrics, Division of Perinatology Zeynep Kamil Kadın ve Çocuk Hastalıkları Eğitim ve Araştırma Hastanesi Istanbul Turkey
2 shared publications - Özge Kahramanoğlu
Department of Obstetrics and Gynecology , University of Health Sciences Şehit Prof. Dr. Ilhan Varank Training and Research Hospital , Istanbul , Türkiye
2 shared publications
Latest Publications
- 11 November 2022
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 42 (8) , 3477-3483
Intraamniotic digoxin administration versus intracardiac or funic potassium chloride administration to induce foetal demise before termination of pregnancy: a prospective study
Different foeticide techniques and pharmacological agents have been used to achieve foetal asystole. This study aimed to compare the success of intraamniotic digoxin, intracardiac potassium chloride (KCl), and funic KCl in achieving foetal asystole and discuss procedural difficulties for physicians and clinical outcomes. This prospective observational study included 124 patients who received foeticide at 22–31 weeks of gestation. All procedures were performed transabdominally, and 1 mg of intraamniotic digoxin, funic KCl, or intracardiac KCl was administered. Procedure times, procedural difficulty scores, patient pain scores, decrease in haematocrit levels, induction and hospitalisation times, and the presence of chorioamnionitis were recorded. The foeticide success rates were 93.0, 95.1, and 97.5% for intraamniotic digoxin, intracardiac KCl, and funic KCl, respectively. Intraamniotic digoxin was associated with shorter procedure times, lower procedural difficulty scores, and lower patient pain scores (p < 0.001). Decreases in haematocrit, induction times, and chorioamnionitis were similar in all three procedures. Success rates and clinical results were similar for all three procedures. Foeticide with intra-amniotic digoxin has a high success rate, the procedure is easier to perform, and patients experience less procedural pain.
- 11 November 2022
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 42 (8) , 3477-3483
Intraamniotic digoxin administration versus intracardiac or funic potassium chloride administration to induce foetal demise before termination of pregnancy: a prospective study
Different foeticide techniques and pharmacological agents have been used to achieve foetal asystole. This study aimed to compare the success of intraamniotic digoxin, intracardiac potassium chloride (KCl), and funic KCl in achieving foetal asystole and discuss procedural difficulties for physicians and clinical outcomes. This prospective observational study included 124 patients who received foeticide at 22–31 weeks of gestation. All procedures were performed transabdominally, and 1 mg of intraamniotic digoxin, funic KCl, or intracardiac KCl was administered. Procedure times, procedural difficulty scores, patient pain scores, decrease in haematocrit levels, induction and hospitalisation times, and the presence of chorioamnionitis were recorded. The foeticide success rates were 93.0, 95.1, and 97.5% for intraamniotic digoxin, intracardiac KCl, and funic KCl, respectively. Intraamniotic digoxin was associated with shorter procedure times, lower procedural difficulty scores, and lower patient pain scores (p < 0.001). Decreases in haematocrit, induction times, and chorioamnionitis were similar in all three procedures. Success rates and clinical results were similar for all three procedures. Foeticide with intra-amniotic digoxin has a high success rate, the procedure is easier to perform, and patients experience less procedural pain.
- 22 September 2022
- Published by Taylor & Francis in Journal of Psychosomatic Obstetrics & Gynecology
- Vol. 43 (4) , 585-592
Positive effects of fetal echocardiography on maternal anxiety: a prospective study in a tertiary center in Turkey
Aim: The aim of this study was to determine the anxiety levels of pregnant women who were referred to a tertiary center for fetal echocardiography (FE) and the effect of FE results on maternal anxiety. Methods: This prospective study was conducted between January 2020 and February 2021 and included 118 pregnant women. The anxiety levels of the participants were evaluated with the Spielberger State-Trait Anxiety Inventory, which evaluates state (STAI-I) and trait (STAI-II) anxiety. STAI-I and STAI-II were administered to participants at first admission using a standard interview technique prior to FE. After the FE was completed, a structured interview was performed and the state anxiety index (STAI-I-R) was re-administered to the participants. Results: Severe congenital heart disease (CHD) was detected in 63 (53.4%) fetuses. The participants’ mean STAI-I scores were significantly higher than their mean STAI-II scores (44.19 ± 8.56 and 41.98 ± 5.98, respectively, t = 2.59 and p = 0.011). In pregnant women with fetuses with severe CHD, STAI-I-R scores were significantly lower compared to STAI-I scores (43.48 ± 7.97 and 46.28 ± 7.18, respectively, t = 2.13 and p = 0.037). Conclusion: Referral for FE is associated with increased maternal anxiety, and a structured interview may result in reduced anxiety levels even in those with abnormal FE.
- 22 September 2022
- Published by Taylor & Francis in Journal of Psychosomatic Obstetrics & Gynecology
- Vol. 43 (4) , 585-592
Positive effects of fetal echocardiography on maternal anxiety: a prospective study in a tertiary center in Turkey
Aim: The aim of this study was to determine the anxiety levels of pregnant women who were referred to a tertiary center for fetal echocardiography (FE) and the effect of FE results on maternal anxiety. Methods: This prospective study was conducted between January 2020 and February 2021 and included 118 pregnant women. The anxiety levels of the participants were evaluated with the Spielberger State-Trait Anxiety Inventory, which evaluates state (STAI-I) and trait (STAI-II) anxiety. STAI-I and STAI-II were administered to participants at first admission using a standard interview technique prior to FE. After the FE was completed, a structured interview was performed and the state anxiety index (STAI-I-R) was re-administered to the participants. Results: Severe congenital heart disease (CHD) was detected in 63 (53.4%) fetuses. The participants’ mean STAI-I scores were significantly higher than their mean STAI-II scores (44.19 ± 8.56 and 41.98 ± 5.98, respectively, t = 2.59 and p = 0.011). In pregnant women with fetuses with severe CHD, STAI-I-R scores were significantly lower compared to STAI-I scores (43.48 ± 7.97 and 46.28 ± 7.18, respectively, t = 2.13 and p = 0.037). Conclusion: Referral for FE is associated with increased maternal anxiety, and a structured interview may result in reduced anxiety levels even in those with abnormal FE.